kras mutation and glutathion glynac The roles of in cancer metabolism, tumor microenvironment clinical therapy Targeting KRAS mutations: orchestrating cancer
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges PMC KRAS: feeding pancreatic cancer proliferation: Trends in Biochemical Sciences Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors Metabolic reprogramming in KRAS mutant cancers: Proven targetable vulnerabilities and potential therapeutic strategies ScienceDirect
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1



